Viewpoints: Dual-blocking antibody against VEGF-A and angiopoietin-2 for treating vascular diseases of the eye
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Gou Young Koh | - |
dc.contributor.author | Augustin, Hellmut G. | - |
dc.contributor.author | Campochiaro, Peter A. | - |
dc.date.accessioned | 2022-07-28T04:45:28Z | - |
dc.date.available | 2022-07-28T04:45:28Z | - |
dc.date.created | 2022-04-18 | - |
dc.date.issued | 2022-05 | - |
dc.identifier.issn | 1471-4914 | - |
dc.identifier.uri | https://pr.ibs.re.kr/handle/8788114/11952 | - |
dc.description.abstract | © 2022 Elsevier LtdFaricimab, a bispecific antibody that targets the endothelial cell growth factors vascular endothelial growth factor-A (VEGF-A) and angiopoietin-2 (Angpt2), was recently approved for treating neovascular age-related macular degeneration and diabetic macular edema. Here, Koh and Augustin review how mechanistic studies have translated into therapies, while Campochiaro evaluates their impact and value for clinical practice. | - |
dc.language | 영어 | - |
dc.publisher | Elsevier Ltd | - |
dc.title | Viewpoints: Dual-blocking antibody against VEGF-A and angiopoietin-2 for treating vascular diseases of the eye | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.identifier.wosid | 000796606700002 | - |
dc.identifier.scopusid | 2-s2.0-85127502196 | - |
dc.identifier.rimsid | 78066 | - |
dc.contributor.affiliatedAuthor | Gou Young Koh | - |
dc.identifier.doi | 10.1016/j.molmed.2022.03.004 | - |
dc.identifier.bibliographicCitation | Trends in Molecular Medicine, v.28, no.5, pp.347 - 349 | - |
dc.relation.isPartOf | Trends in Molecular Medicine | - |
dc.citation.title | Trends in Molecular Medicine | - |
dc.citation.volume | 28 | - |
dc.citation.number | 5 | - |
dc.citation.startPage | 347 | - |
dc.citation.endPage | 349 | - |
dc.type.docType | Editorial Material | - |
dc.description.journalClass | 1 | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Cell Biology | - |
dc.relation.journalResearchArea | Research & Experimental Medicine | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Cell Biology | - |
dc.relation.journalWebOfScienceCategory | Medicine, Research & Experimental | - |
dc.subject.keywordAuthor | TIE2 | - |